ZA964480B - Diagnosis of and vaccination against a positive-stranded rna virus using an isolated unprocessed polypeptide encoded by a substantially complete genome of such virus - Google Patents

Diagnosis of and vaccination against a positive-stranded rna virus using an isolated unprocessed polypeptide encoded by a substantially complete genome of such virus

Info

Publication number
ZA964480B
ZA964480B ZA964480A ZA964480A ZA964480B ZA 964480 B ZA964480 B ZA 964480B ZA 964480 A ZA964480 A ZA 964480A ZA 964480 A ZA964480 A ZA 964480A ZA 964480 B ZA964480 B ZA 964480B
Authority
ZA
South Africa
Prior art keywords
virus
diagnosis
isolated
positive
stranded rna
Prior art date
Application number
ZA964480A
Other languages
English (en)
Inventor
Jaw-Ching Liao
Cheng-Nan Wang
Original Assignee
Bionova Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionova Corp filed Critical Bionova Corp
Publication of ZA964480B publication Critical patent/ZA964480B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
ZA964480A 1995-05-31 1996-05-31 Diagnosis of and vaccination against a positive-stranded rna virus using an isolated unprocessed polypeptide encoded by a substantially complete genome of such virus ZA964480B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/454,928 US6153378A (en) 1992-10-16 1995-05-31 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus

Publications (1)

Publication Number Publication Date
ZA964480B true ZA964480B (en) 1996-12-12

Family

ID=23806648

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964480A ZA964480B (en) 1995-05-31 1996-05-31 Diagnosis of and vaccination against a positive-stranded rna virus using an isolated unprocessed polypeptide encoded by a substantially complete genome of such virus

Country Status (10)

Country Link
US (1) US6153378A (fr)
EP (1) EP0828756A2 (fr)
JP (1) JPH11506328A (fr)
KR (1) KR19990022114A (fr)
AU (1) AU5957596A (fr)
BR (1) BR9608676A (fr)
CA (1) CA2222968A1 (fr)
IL (1) IL118471A0 (fr)
WO (1) WO1996038474A2 (fr)
ZA (1) ZA964480B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153392A (en) * 1997-07-30 2000-11-28 Bionova Corporation Devices and methods comprising an HBcAg from hepatitis B virus
US7078500B1 (en) * 1998-01-30 2006-07-18 The General Hospital Corporation Genetic immunization with nonstructural proteins of hepatitis C virus
CA2288869A1 (fr) * 1998-03-04 1999-09-10 Mary Ann Childs Test de confirmation rapide d'infections microbiennes
AU3670999A (en) * 1998-04-30 1999-11-16 Universal Health-Watch, Inc. Immunoassay with mixed peptides
EP1232267B1 (fr) 1999-10-27 2013-03-20 Novartis Vaccines and Diagnostics, Inc. Activation de lymphocytes t specifiques au virus de l'hepatite c
EP1576125A4 (fr) * 2002-10-25 2008-09-03 Novartis Vaccines & Diagnostic Activation de lymphocytes specifiques du vhc
EP1582589B1 (fr) * 2003-01-10 2010-03-24 Protein Crystal Co., Ltd. Complexe de proteines, processus de fabrication et d'utilisation dudit complexe
CA2793959C (fr) 2010-03-25 2019-06-04 Oregon Health & Science University Glycoproteines du cmv et vecteurs recombines
EP2691530B1 (fr) 2011-06-10 2018-03-07 Oregon Health & Science University Glycoprotéines de cmv et vecteurs recombinants cmv
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (fr) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Trimères de glycoprotéines d'enveloppe du vih -1 soluble
KR102268785B1 (ko) 2014-11-27 2021-06-25 킴벌리-클라크 월드와이드, 인크. 표면에서 노로바이러스를 검출하기 위한 장치 및 방법
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (fr) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Trimères de glycoprotéines de l'enveloppe du vih-1 soluble

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049686C (zh) * 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
CH684594A5 (fr) * 1989-12-18 1994-10-31 Wellcome Found Agent viral.
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
WO1991015771A1 (fr) * 1990-04-04 1991-10-17 Chiron Corporation Combinaisons d'antigenes du virus de l'hepatite c (vhc) utilisees dans des immunoanalyses visant a detecter la presence d'anticorps anti-vhc
CA2079912C (fr) * 1990-04-06 2000-07-11 Gregory Reyes Epitopes du virus de l'hepatite c
CA2045326A1 (fr) * 1990-06-25 1991-12-26 Hiroto Okayama Particules du virus de l'hepatite non-a, non-b
ES2273934T5 (es) * 1990-08-25 2011-05-17 Bioprocess Pty Ltd Antígeno del virus de la hepatitis no a, no b, métodos diagnósticos y vacunas.
DE4041304A1 (de) * 1990-12-21 1992-06-25 Mikrogen Molekularbiol Entw Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren
CA2070952A1 (fr) * 1991-06-11 1992-12-12 Makoto Seki Gene du virus de l'hepatite c ou fragment dudit gene, polypeptide code par le gene
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
EP0593291A3 (fr) * 1992-10-16 1995-03-15 Evernew Biotech Inc Protéine nonstructurale du virus de l'hépatite C, et méthode diagnostique et nécessaire.
JP2778886B2 (ja) * 1992-10-16 1998-07-23 エバーニュー バイオテック インコーポレイティド Ｃ型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
KR100312535B1 (ko) * 1993-04-30 2002-06-20 성재갑 혼합항원을이용한씨(c)형간염바이러스의항체진단방법

Also Published As

Publication number Publication date
WO1996038474A3 (fr) 1997-04-24
US6153378A (en) 2000-11-28
JPH11506328A (ja) 1999-06-08
KR19990022114A (ko) 1999-03-25
MX9709271A (es) 1998-10-31
AU5957596A (en) 1996-12-18
EP0828756A2 (fr) 1998-03-18
BR9608676A (pt) 1999-12-07
IL118471A0 (en) 1996-09-12
CA2222968A1 (fr) 1996-12-05
WO1996038474A2 (fr) 1996-12-05

Similar Documents

Publication Publication Date Title
ZA964480B (en) Diagnosis of and vaccination against a positive-stranded rna virus using an isolated unprocessed polypeptide encoded by a substantially complete genome of such virus
AU4803196A (en) Recombinant DNA virus and method for preparation thereof
IL123465A0 (en) 3'Terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
PL321966A1 (en) Vaccine against viral hepatitis of b type
PL324906A1 (en) Vaccines against viral hepatitis of c type
AU8264898A (en) Human jagged polypeptide, encoding nucleic acids and methods of use
IL111475A0 (en) Expression of foreign genes using replicating polyprotein producing virus vectors
ZA961849B (en) Method of purification of recombinant viral vectors containing a therapeutic gene.
AU7319194A (en) Nucleotide and amino acid sequences of the envelope 1 gene of 51 hepatitis c virus isolates and the use of reagents derived therefrom as diagnostic reagents and vaccines
EP0992580A3 (fr) Epitopes de lymphocytes T humains immunodominants du virus de l'hépatite C
IL99401A0 (en) Nucleotide sequence coding for an outer membrane protein and use of said protein in vaccine preparations
AU5552396A (en) Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof
AU2197392A (en) Hepatitis C virus from C-100-3 and env/core regions
EP0276279A4 (fr) Composition et procede d'immunisation contre des agents pathogenes viraux du sida et de l'arc.
AU3406595A (en) Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus
EP0693931A4 (fr) Proteines et peptides immunogenes du cancer et procede d'utilisation
EP0593290A3 (fr) Proteine antigènique du noyau du virus de l'hépatite C, et méthode diagnostiquée et nécessaire.
AU3727895A (en) Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus
HUP9904171A3 (en) Immunogenic peptides of foot-and-mouth disease viruses
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
ZA984232B (en) Grapevine leafroll virus type 2 proteins coding sequences and methods
WO1996040764A3 (fr) Nucleotide et sequences d'acides amines de la region 1 hypervariable du gene e2 du virus de l'hepatite c
CA2275259A1 (fr) Formulations de vaccins a base de papillomavirus recombine
AU6524898A (en) Recombinant microorganisms expressing antigenic proteins of (helicobacter pylori)
ZA964094B (en) Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv)